While serum insulin was not increased in exercised IL-6−/− mice treated with olanzapine, the rise in blood glucose was prevented in these animals providing evidence that protection against olanzapine-induced hyperglycemia with exercise is not mediated by increases in circulating insulin. The gene discussed is IL6; the disease is Hyperglycemia.